About this trial
In this study, the reasons for prolonged hospital stay after thoracoscopic (video- or robot-assisted) anatomical lung resections are investigated. Currently, whenever possible, these anatomical lung resections are performed thoracoscopically, as they offer significant improvements in terms of postoperative pain, number of postoperative complications, rehabilitation, tolerance for adjuvant chemotherapy, and length of hospital stay. The development of an 'Enhanced Recovery After Surgery' (ERAS) protocol for lung surgery has further reduced hospital stay and the need for opioids for analgesia. Despite the optimal implementation of the ERAS protocol, there are still patients who need to stay in the hospital longer than the median. The aim of this research is to investigate the reasons for this.
Eligibility criteria
Qualifiers
Patients referred for elective minimally invasive (uniportal or multiportal video- or robot-assisted) anatomical lung resection (lobectomy or segmentectomy)
Informed consent obtained pre-operatively
Age 18 years or older
Disqualifiers
Patients younger than 18 years old
Traumatic event as indication for lung resection
Non-anatomical lung resections
Thoracotomy
Trial design
Treatments tested in this trial
- VATS/RATS anatomical lung resection
Treatment groups
Sponsors and collaborators
University Hospital, Ghent
Lead sponsor
AZ Sint-Lucas Brugge
Collaborator